A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

November 30, 2002

Conditions
Postherpetic NeuralgiaDiabetic NeuropathyLow Back Pain
Interventions
DRUG

Lidoderm

Patients participated in a 2-week treatment period. Commercially available Lidoderm (lidocaine patch 5%) was provided to patients with up to four patches applied topically once daily (q24h) to the area of maximal peripheral pain.

Trial Locations (11)

Unknown

Birmingham

Phoenix

Plantation

Marietta

Burr Ridge

Overland Park

Hackensack

Altoona

Cudahy

Greenfield

West Bend

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY